Page 3 - Pharmaceutical

Towards greener GST: Rationalisation must align with jobs, sustainability

GST rate rationalisation and expansion must be done not only to achieve simplification but also to subserve large-scale employment and environmental policy goals

Indian pharmaceutical exports ranked 11th globally in 2023: Anupriya Patel

Indian pharmaceutical exports ranked 11th globally in value terms in 2023 and accounted for 3 per cent of the total pharmaceutical exports, Union Minister Anupriya Patel said in Rajya Sabha on Tuesday. The Union Minister of State for Chemicals and Fertilisers gave the information in a written reply to the House, citing a secondary market research analysis published by Bain and Company this year. Replying to a query on whether the quality of Indian pharmaceutical products has often been questioned in some global markets, the minister said the Central Drugs Standard Control Organisation (CDSCO) and Ministry of Health and Family Welfare have taken several measures to ensure quality, safety and efficacy of medicines. To another question, Patel said the mobile app of National Pharmaceuticals Pricing Policy (NPPP), Pharma Sahi Daam (PSD) provides brand name, composition, ceiling price and maximum retail price of drugs for consumer benefit and transparency. She said the entire procedure

Indian pharma market registers 7.5% growth in Feb 2025: Pharmarack

Among them, the cardiac, gastrointestinal, and antidiabetic therapies saw high value growth of 9.5 per cent, 9.6 per cent, and 6 per cent, respectively

Distributed manufacturing may become the future trend: Pharma Inc

Volumes need to be high to justify relocation of manufacturing; strategic decisions cannot be based on current tariff structure

DCGI streamlines drug export approval, plans revised biosimilar guidelines

Previously, companies exporting drugs from India had to apply for a customer- and quantity-specific NOC each time they received an order

MO Alts acquires majority stake in Megafine Pharma for Rs 460 crore

Megafine currently operates two USFDA-approved manufacturing facilities located in Nashik, Maharashtra, and Vapi, Gujarat, and specialises in niche, high-margin APIs, primarily used in chronic disease

CDSCO withdraws export NOC, bans drugs linked to West Africa opioid crisis

The ministry added that Aveo Pharmaceuticals has been issued a Stop Activity Order, halting all operations at the company's premises after a comprehensive audit

Pharma stocks plunge amid tariff concerns, but analysts see limited impact

Pharma stocks fell on Friday on concerns of tariff on imports

NPPA sets prices for 42 drugs, revises ceiling for 2 formulations

Prices have been fixed for drugs and formulations meant for diabetes, hypertension, heart issues, bacterial infections, allergies, and multivitamins

Commerce Ministry withdraws 'track and trace' rule for pharma exports

The Commerce Ministry on Friday said it has withdrawn the provisions related to the track and trace system for pharmaceutical exports under the foreign trade policy. The implementation of the authentication system for drug formulations being exported will be undertaken by the Ministry of Health and Family Welfare in line with the provisions under Drug Rules 1945, according to a public notice of the Directorate General of Foreign Trade (DGFT). "The DGFT has decided to streamline export regulations by aligning with the evolving regulatory framework of the Ministry of Health & Family Welfare. Accordingly, the provisions related to the track and trace system for pharmaceutical exports under the Foreign Trade Policy are being withdrawn," the ministry said. The system, introduced on January 10, 2011, mandated barcoding at various packaging levels. While tertiary and secondary packaging requirements were successfully implemented in 2011 and 2013, primary-level barcoding and parent-child .

OneSource sees surge in demand as semaglutide patents near expiry

The company emphasised that it is ready to meet the growing demand for drug-device combinations and biologics, with semaglutide formulations being a focal point

Mankind Pharma Q3FY25 results: PAT falls 16.5%, revenue rises 24%

Mankind's revenue from operations rose to Rs 3,230 crore in Q3FY25, a 24 per cent Y-o-Y rise from Rs 2,607 crore reported in Q3FY24

PharmEasy founders step back to launch new venture in consumer space

Siddharth Shah, chief executive officer (CEO) and managing director (MD) of PharmEasy has also invested in the new venture in his personal capacity

Sun Pharma's unit Taro to acquire 100% stake in Antibe Therapeutics

The acquisition is expected to be completed before March 7, 2025, subject to approval from the Ontario Superior Court of Justice

PAG acquires majority stake in Pravesha Industries for $200 million

PAG had earlier acquired Manjushree Technopack for $1bn

Lupin receives US FDA tentative approval for Ivacaftor Oral Granules

These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral Granules

Lupin gets clearance from USFDA for its Pithampur manufacturing facility

Lupin, headquartered in Mumbai, India, is a global pharmaceutical player with products distributed in over 100 markets

Assembly lines adopt flexible robotics to meet rising consumer expectations

These systems can be deployed across various industries ranging from pharmaceuticals, and consumer goods to the automotive sector

Budget wishlist: Pharma firms seek simplified taxes, stronger PLI scheme

Among other demands is the removal of Section 194R, related to marketing samples, which would ease business operations

Pharmed Ltd chairman emeritus Krishan Kumar Aurora passes away at 88

Krishan Kumar Aurora, chairman emeritus of Pharmed Limited and BioPlus Group, passed away on December 23 at 88. He began his career in 1961 with Smith Kline & French, rising to VP for Southeast Asia